ACGT Awards Luncheon Honors Crystal Mackall, MD, With Edward Netter Leadership Award

Article

Alliance for Cancer Gene Therapy (ACGT) awarded The Edward Netter Leadership Award to Crystal Mackall, MD, of Stanford University.

Alliance for Cancer Gene Therapy (ACGT) awarded The Edward Netter Leadership Award to Crystal Mackall, MD, of Stanford University, at the ACGT Awards Luncheon on March 30 at Riverpark restaurant at the Alexandria Center for Life Science in New York City.

Crystal Mackall, MD Edward Netter Leadership Award | Image Credit: ACGT

Crystal Mackall, MD, right, received The Edward Netter Leadership Award during the ACGT Awards Luncheon earlier this year. Carl June, MD, left, the 2019 recipient of the award, presented it to Dr. Mackall.

The ACGT Awards Luncheon celebrated the non-profit organization’s 20th anniversary and ushered in a new decade. The event was held during the intermission of the ACGT Summit 2023.

Attendees, including scientists and donors, helped ACGT recognize Dr. Mackall for her incredible achievements, such as the numerous groundbreaking clinical trials she has led to treat children with sarcomas and brain cancers. Named for ACGT co-founder, Edward Netter, the award recognizes a researcher who has made unparalleled and groundbreaking contributions to the field of cell and gene therapy for cancer.

“Without the donors, Alliance for Cancer Gene Therapy doesn’t exist,” Dr. Mackall said, later adding that “you get (a foundation like ACGT) by having a leadership with great instincts, leadership that is passionate, and leadership that has grit.”

Read more about Dr. Mackall’s recognition and the ACGT Awards Luncheon on the foundation’s website.

Related Videos
Casey Maguire, PhD, associate professor of neurology and associate investigator of neurology, Harvard Medical School
Evan Weber, PhD, an assistant professor of pediatrics at Children's Hospital of Philadelphia
Debora Mazzetti, MS, on Multitargeting MicroRNA in Glioblastoma
Francesca Del Bufalo, MD, PhD, a medical doctor and scientist at Bambino Gesù Chidren’s Hospital
Carlos Ramos, MD, on Alternatives to T-Cell Therapy
Omid Hamid, MD
Alexandra Gomez-Arteaga, MD
Pietro Genovese, PhD, the principal investigator at the Gene Therapy Program of Dana-Farber/Boston Children’s Cancer and Blood Disorder Center
Caspian Oliai, MD, MS, the medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center
Genovefa (Zenia) Papanicolaou, MD, an infectious diseases specialist at Memorial Sloan Kettering Cancer Center
© 2024 MJH Life Sciences

All rights reserved.